INIFY Laboratories AB (OSL:INIFY)
Norway · Delayed Price · Currency is NOK 5.60
-0.30 (-5.08%)
At close: Aug 14, 2025
INIFY Laboratories AB Company Description
INIFY Laboratories AB provides cancer diagnostics services in Sweden. It offers prostate cancer diagnostics services. The company was incorporated in 2021 and is based in Stockholm, Sweden.
INIFY Laboratories AB
| Country | Sweden |
| Founded | 2021 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | Fredrik Palm |
Contact Details
Address: Hollandargatan 13 Stockholm, 111 36 Sweden | |
| Phone | 46 08 26 73 30 |
| Website | inify.com |
Stock Details
| Ticker Symbol | INIFY |
| Exchange | Oslo Børs |
| Reporting Currency | NOK |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| Fredrik Palm | Chief Executive Officer |
| Ann-Charlotte Linderoth | Chief Financial Officer |
| Emelie Edvigsson | Chief Operating Officer |
| Arto Jarvinen | Chief Technical Officer |
| Dr. Claes Lindh | Chief Medical Officer |
| Johanna Karling | Chief Quality and Regulatory Affairs Officer |
| Magnus Aurell | Chief Commercial Officer |